Correlation Between BioSig Technologies, and Abbott Laboratories

Can any of the company-specific risk be diversified away by investing in both BioSig Technologies, and Abbott Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioSig Technologies, and Abbott Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioSig Technologies, Common and Abbott Laboratories, you can compare the effects of market volatilities on BioSig Technologies, and Abbott Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioSig Technologies, with a short position of Abbott Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioSig Technologies, and Abbott Laboratories.

Diversification Opportunities for BioSig Technologies, and Abbott Laboratories

-0.7

Correlation Coefficient

BioSig Technologies,  Abbott Laboratories

Excellent diversification

The 3 months correlation between BioSig and Abbott is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding BioSig Technologies, Common and Abbott Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abbott Laboratories and BioSig Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioSig Technologies, Common are associated (or correlated) with Abbott Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abbott Laboratories has no effect on the direction of BioSig Technologies, i.e., BioSig Technologies, and Abbott Laboratories go up and down completely randomly.

Pair Corralation between BioSig Technologies, and Abbott Laboratories

Given the investment horizon of 90 days BioSig Technologies, Common is expected to generate 8.17 times more return on investment than Abbott Laboratories. However, BioSig Technologies, is 8.17 times more volatile than Abbott Laboratories. It trades about 0.13 of its potential returns per unit of risk. Abbott Laboratories is currently generating about 0.29 per unit of risk. If you would invest  92.00  in BioSig Technologies, Common on November 29, 2024 and sell it today you would earn a total of  16.00  from holding BioSig Technologies, Common or generate 17.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.45%
Values	Daily Returns

BioSig Technologies, Common  vs.  Abbott Laboratories

BioSig Technologies,

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioSig Technologies, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Abbott Laboratories

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal fundamental drivers, Abbott Laboratories unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BioSig Technologies, and Abbott Laboratories

The main advantage of trading using opposite BioSig Technologies, and Abbott Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioSig Technologies, position performs unexpectedly, Abbott Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will offset losses from the drop in Abbott Laboratories' long position.

The idea behind BioSig Technologies, Common and Abbott Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.